HLA-C and neoplasm: Resistance to immunotherapy is caused by many factors including upregulation of immune checkpoints in the TME, downregulation of MHC molecules in tumor cells, loss of target antigens and secretion of immune suppressive signals by tumor-associated macrophages (TAMs), myeloid-derived suppressor cells (MDSCs) and T regulatory cells (Tregs) [15].